Here are five key points:
1. Six centers in Massachusetts, New Hampshire, Connecticut and Texas are participating in Carevature’s Dreal limited market launch in the United States.
2. Globally, surgeons have used Dreal products on more than 400 patients.
3. Dreal features a curved design intended to cause less trauma and quicken recovery by preserving the tissue.
4. Carevature plans a full commercial launch for Dreal in 2017.
5. Carevature develops orthopedic surgery solutions.
More articles on devices:
Michigan invests $1M in Stryker to convince company to expand in state — 4 things to know
What’s the future of the global joint repair market: 5 key notes
Stryker hip implant recall adds more patients: 3 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
